Registered entity data
In general | ||||||
| Enterprise number: | 1002.863.501 | |||||
| Status: | Active | |||||
| Legal situation: | Normal situation Since November 30, 2023 | |||||
| Start date: | November 30, 2023 | |||||
| Name: | SAMABRIVA BIOMANUFACTURING Name in French, since November 30, 2023 | |||||
| Registered seat's address: |
Avenue Pré-Aily 14
4031 Liège Since January 29, 2025 | |||||
| Phone number: |
| |||||
| Fax: | No data included in CBE. | |||||
| Email address: |
| |||||
| Web Address: | No data included in CBE. | |||||
| Entity type: | Legal person | |||||
| Legal form: |
Public limited company
Since November 30, 2023 | |||||
| Number of establishment units (EU): | 1
Information and activities for each establishment unit | |||||
| | ||||||
Functions | ||||||
| There are 6 legal functions for this entity. Show the legal functions. | ||||||
| | ||||||
Entrepreneurial skill - Travelling- Fairground operator | ||||||
| No data included in CBE. | ||||||
| | ||||||
Characteristics | ||||||
| Employer National Social Security Office Since August 12, 2024 | ||||||
| Subject to VAT Since January 1, 2024 | ||||||
| Enterprise subject to registration Since December 30, 2023 | ||||||
| | ||||||
Authorisations | ||||||
| No data included in CBE. | ||||||
| | ||||||
Version of the Nacebel codes for the VAT activities 2025(1) | ||||||
| VAT 2025
70.200
-
Business and other management consultancy activities Since January 1, 2025 | ||||||
| VAT 2025
72.101
-
Research and experimental development on biotechnology Since January 1, 2025 | ||||||
| VAT 2025
46.460
-
Wholesale of pharmaceutical and medical goods Since January 1, 2025 | ||||||
| VAT 2025
72.109
-
Research and experimental development on other natural sciences and engineering Since January 1, 2025 | ||||||
| VAT 2025
20.420
-
Manufacture of perfume and toilet preparations Since January 1, 2025 | ||||||
| VAT 2025
21.201
-
Manufacture of medicaments Since January 1, 2025 | ||||||
| | ||||||
Version of the Nacebel codes for the NSSO activities 2025(1) | ||||||
| NSSO2025
21.201
-
Manufacture of medicaments Since January 1, 2025 | ||||||
| Show the NACE-BEL codes activities version 2008. | ||||||
| | |||
Financial information | |||
| Capital | 150.000,00 EUR | ||
| Annual assembly | May | ||
| End date financial year | 31 December | ||
| Start date exceptional fiscal year | November 29, 2023 | ||
| End date exceptional fiscal year | December 31, 2024 | ||
| | |||
Links between entities | |||
| No data included in CBE. | |||
| | |||
External links | |||
|
Publications in National Gazette
Publication of the annual accounts in the Central Balance Sheet Office Database of statutes and powers of representation (notarial deeds) Employers' repertory Check withholding obligation Central Register of Director Disqualifications - log in | |||
(1)Activities are registered in the CBE using NACE-BEL codes (Belgian classification of activities). Activities registered of the NACE-BEL codes (version 2003) were stopped on 31/12/2007, automatically converted to the NACE-BEL codes (version 2008) and registered with a start date of 01/01/2008. This was a mere administrative conversion and no modification of the activity itself.
(2)Activities are registered in the CBE using NACE-BEL codes (Belgian classification of activities). Following a conversion of activities with a NACE-BEL code (2003 version) to NACE-BEL codes (2008 version), the start date of activities (2008 version) is 1/01/2008. Activities with a NACE-BEL code (2008 version) were then stopped on 31/12/2024 and automatically converted to NACE-BEL codes (2025 version). These were mere administrative conversion and no modification of the activity itself. The 2003 activities can be accessed by clicking on the link : "Show the NACE-BEL codes activities version 2003".
To top Back

